Key Highlights

  • Q1 adjusted earnings per share reached 55 cents for DuPont, surpassing analyst projections of 48 cents
  • Revenue totaled $1.68 billion for the quarter, marginally exceeding the $1.67 billion forecast
  • Annual EPS projections elevated to $2.35–$2.40 range, compared with previous $2.25–$2.30 outlook
  • Management initiated a $275 million accelerated share buyback program with immediate effect
  • Pricing adjustments of approximately 1% implemented to counter elevated input expenses linked to Iran tensions

Shares of DuPont (DD) advanced 1.6% to reach $46.15 during premarket hours on Tuesday following the materials and chemicals manufacturer’s first-quarter performance that topped analyst projections and prompted management to elevate annual forecasts.


DD Stock Card
DuPont de Nemours, Inc., DD

The company delivered adjusted earnings of 55 cents per share, comfortably exceeding the 48-cent consensus compiled by FactSet. Revenue climbed to $1.68 billion from $1.61 billion in the corresponding period last year, narrowly surpassing the $1.67 billion analyst estimate.

On a GAAP basis, DuPont reported profitability of $161 million, translating to 39 cents per share, representing a sharp reversal from the $589 million loss, or $1.40 per share, recorded in the year-ago quarter.

Year-over-year comparisons require context given corporate restructuring. The company completed the separation of its electronics division, Qnity Electronics, creating differences in comparable figures across periods.

The first-quarter performance includes a three-cent-per-share benefit from discontinued operations connected to the sale of the Aramids business, which reached completion on April 1.

Annual Projections Move Higher

Management elevated full-year adjusted earnings expectations to a range of $2.35 to $2.40 per share, an increase from the previously communicated $2.25 to $2.30 target. Revenue guidance also received an upward adjustment to $7.16–$7.22 billion from the earlier $7.08–$7.14 billion range.

These revised projections position the company above current Street expectations, which stand at $2.27 per share and $7.10 billion in revenue.

Second-quarter guidance calls for adjusted earnings of approximately 59 cents per share on revenue near $1.8 billion. Analyst consensus had anticipated 58 cents on $1.8 billion in sales, placing the outlook closely aligned with expectations.

Chief Executive Lori Koch highlighted organic expansion, margin improvement, and double-digit adjusted earnings growth as standout achievements from the quarter. Chief Financial Officer Antonella Franzen explained that updated annual projections incorporate approximately 4% organic growth, with roughly 1% attributable to pricing actions designed to offset elevated input expenses stemming from tensions involving Iran.

Capital Return Initiative and Operational Results

The company unveiled a $275 million accelerated share repurchase program launching without delay. This initiative represents a portion of the broader $2 billion buyback authorization the board granted in November, which featured a $500 million accelerated component.

Looking at operational segments, Healthcare & Water Technologies generated 6% year-over-year revenue growth, while profit margins expanded by 1.1 percentage points. The Diversified Industrials segment delivered 3% sales advancement, accompanied by an identical 1.1 percentage point margin enhancement.

DD shares had declined approximately 9% following the commencement of hostilities involving Iran on February 28, as market participants assessed potential impacts from higher oil prices on production costs. Entering Tuesday’s session, the stock maintained a 13% gain year-to-date and had appreciated 66% over the trailing twelve months.

The second-quarter outlook calling for 59 cents in adjusted earnings per share on $1.8 billion in revenue represents the company’s latest forward guidance.